Who We Are
Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.
Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.
Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.
Key Issues
Causes We Care About, and So Should You!
HIV
Promote necessary funding, programs, and policies to end the HIV epidemic in the United States
HEPATITIS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
HEALTHCARE ACCESS
Promote necessary funding, programs, and policies to end viral hepatitis in the United States
Facebook posts by @HIV+Hep
Experts Highlight Alarming Jump in HIV Infections Among Latinos
In a perspective piece, they argue that more equitable resource allocation is neededTwice-Yearly PrEP Shows Promise, Could Boost Adherence
Recently publicized data from a late-stage clinical trial for an HIV PrEP therapy showed promise for twice-yearly treatments.Trends in Oral and Injectable HIV Preexposure Prophylaxis Prescriptions in the US, 2013-2023
This study examines the prescribing trends of 3 oral preexposure prophylaxis medications and a long-acting injectable option from 2013 to 2023.‘I’m another statistic. I feel let down’: How HIV prevention stays out of reach for many
This story was reported in partnership with Uncloseted Media, a nonpartisan, investigative, LGBTQ | Ending the HIV epidemic hinges on both treatment and prevention, particularly through access to PrEP...Biden-Harris must ensure access to HIV prevention drugs
The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are hitting the . . .